| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/07/2007 | WO2007099788A1 Method of monitoring component concentration of staining solution |
| 09/07/2007 | WO2007099451A1 Method for identifying useful proteins of brewery yeast |
| 09/07/2007 | WO2007099380A1 Heterodimer complexes of the abcg5 and abcg8 proteins and methods for screening modulators thereof |
| 09/07/2007 | WO2007099341A1 T cell assays |
| 09/07/2007 | WO2007099338A1 Method and apparatus for detecting a substance of interest |
| 09/07/2007 | WO2007099312A1 Apparatus and methods for imaging and modification of biological samples |
| 09/07/2007 | WO2007099289A1 Targeted iron oxide nanoparticles |
| 09/07/2007 | WO2007099192A1 Method for detecting glycogen by means of fluorescence |
| 09/07/2007 | WO2007099133A1 Screening for anti-cancer compounds using netrin-1 activity |
| 09/07/2007 | WO2007098933A1 High-throughput cell-based screening system |
| 09/07/2007 | WO2007098921A1 Test apparatus, production method therefor and test method |
| 09/07/2007 | WO2007098859A1 Mass spectrometric determination of blood enzyme activity |
| 09/07/2007 | WO2007098755A1 A method for obtaining a microarray and an assay |
| 09/07/2007 | WO2007098625A1 Method for assessing absorption properties of low solubility compounds |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007098585A1 Methods for the diagnosis of dementia and other neurological disorders |
| 09/07/2007 | WO2007098576A1 Microplate assay kit |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007098555A1 Method and apparatus for containment and decontamination |
| 09/07/2007 | WO2007084001A3 Means and methods for modulating stem cell mobilization |
| 09/07/2007 | WO2007082909A3 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 09/07/2007 | WO2007082833A8 Method and diagnostic kit for simultaneous identification and quantification of individual biomolecules or biomolecules which are present in mixtures and their modifications |
| 09/07/2007 | WO2007081868A9 Determination of concentration of fk778 by competitive immunoassay |
| 09/07/2007 | WO2007081851A3 Affinity chromatography matrices and methods of making and using the same |
| 09/07/2007 | WO2007081804A9 Regulators of nfat |
| 09/07/2007 | WO2007079516A3 Sensor device and method for monitoring a fuel cell system |
| 09/07/2007 | WO2007079257A3 Integrated dissolution processing and sample transfer system |
| 09/07/2007 | WO2007076601B1 Imaging of d2high receptors using radiolabelled (-)- quinpirole and analogs thereof |
| 09/07/2007 | WO2007076294A3 Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease |
| 09/07/2007 | WO2007075915A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007075914A3 Monoclonal antibodies against orthopoxviruses |
| 09/07/2007 | WO2007071927A3 Fluorescent dyes and complexes |
| 09/07/2007 | WO2007068982A3 Detection of antibodies |
| 09/07/2007 | WO2007067732A3 A scintillation proximity assay for identifying inhibitors of fatty acid amide hydrolase |
| 09/07/2007 | WO2007067473A3 Perhydrolase epitopes |
| 09/07/2007 | WO2007062105A8 Multiplex digital immuno-sensing using a library of photocleavable mass tags |
| 09/07/2007 | WO2007060568A3 Magnetic sensor device with sample chamber |
| 09/07/2007 | WO2007060240A3 Method for demonstrating presence or absence of markers (eef1a1 or mark3 )associated with the presence and/or the chemosensitivity of tumors |
| 09/07/2007 | WO2007059910A9 Device for analysing sample fluids containing suspended materials |
| 09/07/2007 | WO2007057644A3 Method of measuring the affinity of biomolecules |
| 09/07/2007 | WO2007050318A3 Lipidomics approaches for central nervous system disorders |
| 09/07/2007 | WO2007046051A3 Magnetoresistive nanoparticle sensor |
| 09/07/2007 | WO2007042827A3 Treatment and diagnosis of obligate intracellular pathogens |
| 09/07/2007 | WO2007027636A3 Method for treatment or prevention of conditions caused by gram-positive bacteria |
| 09/07/2007 | WO2006137891A8 Membrane with nanochannels for detection of molecules |
| 09/07/2007 | WO2006124866A3 Free human serum ige immunoenzymetric assay and methods of use |
| 09/07/2007 | WO2006117538A3 Assays for diagnosis of tuberculosis and uses thereof |
| 09/07/2007 | WO2006114081A3 Grid sensor |
| 09/07/2007 | WO2006113198A3 Methods of enhancing isolation of rna from biological samples |
| 09/07/2007 | WO2006107670A3 In vitro association studies |
| 09/07/2007 | WO2006058334A3 Prticle-based multiplex assay for identifying glycosylation |
| 09/07/2007 | WO2005094259A8 Leptin binding domain compositions and methods thereto |
| 09/07/2007 | WO2005047468A8 Improved methods for detecting and measuring specific nucleic acid sequences |
| 09/07/2007 | WO2005037231A3 Methods of detecting and treating facioscapulohumeral muscular dystrophy |
| 09/07/2007 | WO2004061418A3 Assay cartridges and methods of using the same |
| 09/07/2007 | CA2689848A1 Methods for the diagnosis of dementia and other neurological disorders |
| 09/07/2007 | CA2644540A1 T cell assays |
| 09/07/2007 | CA2643846A1 Methods for predicting cellular toxicity upon treatment with tyrosine kinase inhibitors |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2643476A1 Method for assessing absorption properties of low solubility compounds |
| 09/07/2007 | CA2643360A1 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 09/07/2007 | CA2643273A1 Biosensor |
| 09/07/2007 | CA2643163A1 Temperature-adjusted analyte determination for biosensor systems |
| 09/07/2007 | CA2642994A1 Immunogenic page-4 peptides and methods of use |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2642769A1 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 09/07/2007 | CA2640551A1 Apparatus and methods for imaging and modification of biological samples |
| 09/07/2007 | CA2639148A1 Method for identifying useful proteins of brewery yeast |
| 09/07/2007 | CA2638974A1 Screening for anti-cancer compounds using netrin-1 activity |
| 09/07/2007 | CA2638943A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | CA2638825A1 Transcription factor arntl2 gene and expression products thereof used in the diagnosis, prevention, and treatment of type 1 diabetes |
| 09/07/2007 | CA2638735A1 Methods to identify inhibitors of the unfolded protein response |
| 09/07/2007 | CA2538361A1 Proteomic methods for the identification of differentiated adipose cells and adipose-devired adult stem cells |
| 09/06/2007 | US20070208539 Producing system and its control device, control method, control system and control program |
| 09/06/2007 | US20070208514 Method of Preparing Disease Prognosis Model, Disease Prognosis Prediction Method using this Model, Prognosis Prediction Device Based on this Model, and Program for Performing the Device and Storage Medium Wherein Said Program is Stored |
| 09/06/2007 | US20070208237 Method of using a micro optical sensor device |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/06/2007 | US20070208169 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors |
| 09/06/2007 | US20070207993 Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases |
| 09/06/2007 | US20070207986 Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders |
| 09/06/2007 | US20070207974 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 09/06/2007 | US20070207943 Interleukins-21 and 22 |
| 09/06/2007 | US20070207555 Ultra-sensitive detection systems using multidimension signals |
| 09/06/2007 | US20070207554 Medical System and Method for Determining Parameters |
| 09/06/2007 | US20070207553 High sensitivity biomolecule detection with magnetic particles |
| 09/06/2007 | US20070207552 Device for investigating chemical interactions and process utilizing such device |
| 09/06/2007 | US20070207551 Method for the assessment of particles and a system and device for use in the method |
| 09/06/2007 | US20070207549 Method and apparatus for DNA collection |
| 09/06/2007 | US20070207548 Microflow System for Particle Separation and Analysis |
| 09/06/2007 | US20070207547 Scintillation proximity test |
| 09/06/2007 | US20070207539 Lymphocytes; immunoglobulins; point mutations |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207515 Method Of Multiquantification For Cholesterol Of Low-Density Lipoprotein |
| 09/06/2007 | US20070207513 Methods, Products, and Kits for Identifying an Analyte in a Sample |
| 09/06/2007 | US20070207511 Methods for identification, assessment, prevention, and therapy of cancer |
| 09/06/2007 | US20070207510 Methods and compounds for lymphoma cell detection and isolation |
| 09/06/2007 | US20070207509 Zinc-based screening test and kit for early diagnosis of prostate cancer |
| 09/06/2007 | US20070207508 Method and assay kit for simultaneously detecting multiple tumor markers with interference indication |